Market Highlights —
Onychomycosis is a fungal infection occur in nails that causes discoloration, thickening and separation from the nail bed. 50% of the total onychomycosis occurs in people older than 70 years as increasing age led to decrease in immune system. Risk of onychomycosis increases in patient with AIDS, diabetes, immunological diseases and increasing age. According to the World Health Organization (WHO) there were approximately 36.7 million people worldwide living with HIV/AIDS by the end of 2015. The major driving factors for the growth of the market are, increasing prevalence of onychomycosis, diabetes, AIDS and different immunological diseases. Whereas adverse effects of the treatment and lack of awareness among people has restrained the growth of market. The global onychomycosis market is expected to grow at a CAGR of 7.9% during forecasted period.
Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/1340
Key players for global onychomycosis market
• Abbott Laboratories Ltd. (US),
• GlaxoSmithKline Plc. (UK),
• Pfizer Inc. (US),
• Valeant Pharmaceuticals (Canada),
• Galderma (Switzerland),
• Janssen Biotech (US),
• Sciton Inc (US),
• Bristol Meyer Squibb company (US),
• Cutera Inc. (US),
• Novartis AG (Switzerland),
• Sanofi Ltd. (France),
• Topica Pharmaceuticals Inc. (US),
• Taro Pharmaceutical Industries Ltd. (US),
• Seren Pharmaceuticals Pvt. Ltd (China),
• Nuvo Research Inc. (Canada),
• Merz Pharma gmbh & co. kgaa (Germany),
• NanoBio Corporation (US),
• NovaBiotics Ltd (UK),
• Viamet Pharmaceuticals Inc. (US),
• Polichem SA (Switzerland)
Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Onychomycosis Market - Global Forecast till 2023”
Global onychomycosis market is saturated by presence of number of small and medium sized companies. Some of them are focusing on the development of the new products for the treatment while some are collaborating with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care.
Commenting on the report, an analyst from Market Research Future (MRFR)’s team said: Global onychomycosis market is expecting a sound growth in the coming future. The risk of onychomycosis is two times higher in person with diabetes as compared to the general population. Increasing prevalence in older adults, immunologic disorders and diabetes mellitus has increase the risk of people to suffer from onychomycosis. Increasing demand for better treatment of onychomycosis and increasing prevalence of different immunological diseases has driven the growth of the market. Lack of awareness and side effects of the treatment has hampered the growth of the market.
Browse full report @ https://www.marketresearchfuture.com/reports/onychomycosis-market
Table of Content
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
3.4 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
5. Global Onychomycosis Market, By Type
Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Release ID: 225491